We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Anticoagulation therapy of vascular thrombotic diseases and new progress of Rivaroxaban application.
- Authors
ZHAO Ziyuan; ZHANG Xiujun
- Abstract
Incidence of thrombotic disease is very high, and this disease can result in high mortality and high disability rate. Prevention and treatment of the disease mainly include: antiplatelet, anticoagulation and thrombolysis. Choice of anti-thrombotic treatment based emphasizes on individuation. As a direct inhibitor of factor Xa, Rivaroxaban exert its anticoagulant activity without antithrombin III but is ineffective to the Xa in prothrombin complex, which can be used as a substitute of traditional anticoagulant. In this paper, applications of Rivaroxaban on treating symptomatic venous thromboembolic disease, postoperative venous thrombosis and cardiovascular thrombosis are reviewed.
- Subjects
CARDIOVASCULAR disease treatment; THROMBOSIS; PLATELET aggregation inhibitors; ANTICOAGULANTS; THROMBOLYTIC therapy; RIVAROXABAN
- Publication
Tianjin Medical Journal, 2015, Vol 43, Issue 4, p446
- ISSN
0253-9896
- Publication type
Article
- DOI
10.11958/j.issn.0253-9896.2015.04.031